MX2007003162A - Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa. - Google Patents
Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa.Info
- Publication number
- MX2007003162A MX2007003162A MX2007003162A MX2007003162A MX2007003162A MX 2007003162 A MX2007003162 A MX 2007003162A MX 2007003162 A MX2007003162 A MX 2007003162A MX 2007003162 A MX2007003162 A MX 2007003162A MX 2007003162 A MX2007003162 A MX 2007003162A
- Authority
- MX
- Mexico
- Prior art keywords
- polydextrose
- continuous
- phase
- polymer
- polymer matrix
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere a una composicion farmaceutica solida que comprende una dispersion solida que contiene al menos un principio activo y una matriz polimerica farmaceuticamente aceptable. La invencion se caracteriza porque la matriz polimerica farmaceuticamente aceptable comprende una mezcla de (i) polidextrosa, en la forma de una fase continua de polidextrosa, a fin de favorecer la desintegracion de la composicion en un medio acuoso y (ii) al menos un polimero diferente a la polidextrosa, en la forma de una fase continua, mediante la cual la polidextrosa se encuentra en una concentracion de al menos 20% en peso y al menos un polimero diferente a la polidextrosa se encuentra en una concentracion de al menos 20% en peso en relacion al peso total de la matriz polimerica farmaceuticamente aceptable.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0409874A FR2875409B1 (fr) | 2004-09-17 | 2004-09-17 | Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose |
PCT/FR2005/002288 WO2006032762A2 (fr) | 2004-09-17 | 2005-09-15 | Composition pharmaceutique comprenant une dispersion solide a matrice polymere comprenant une phase continue de polydextrose et une phase continue d'un polymere autre que du polydextrose |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007003162A true MX2007003162A (es) | 2007-05-16 |
Family
ID=34948358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007003162A MX2007003162A (es) | 2004-09-17 | 2005-09-15 | Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa. |
Country Status (18)
Country | Link |
---|---|
US (1) | US9084730B2 (es) |
EP (1) | EP1791524B1 (es) |
JP (1) | JP5224812B2 (es) |
KR (1) | KR101342193B1 (es) |
CN (2) | CN101039657B (es) |
AU (1) | AU2005286396B2 (es) |
BR (1) | BRPI0515390A (es) |
CA (1) | CA2579673C (es) |
EA (1) | EA012850B1 (es) |
FR (1) | FR2875409B1 (es) |
HK (1) | HK1111608A1 (es) |
IL (1) | IL181773A0 (es) |
MA (1) | MA28858B1 (es) |
MX (1) | MX2007003162A (es) |
NO (1) | NO20071853L (es) |
NZ (1) | NZ553780A (es) |
WO (1) | WO2006032762A2 (es) |
ZA (1) | ZA200702214B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7973025B2 (en) | 2005-05-26 | 2011-07-05 | Neuron Systems, Inc. | Compositions and methods of treating retinal disease |
CN103735515A (zh) * | 2006-02-09 | 2014-04-23 | 默沙东公司 | Cetp抑制剂的聚合物制剂 |
US20100080852A1 (en) * | 2007-05-03 | 2010-04-01 | Ronald Arthur Beyerinck | Phamaceutical composition comprising nanoparticles and casein |
FR2921835B1 (fr) * | 2007-10-05 | 2012-05-04 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Composition d'enrobage comprenant du polydextrose, procede pour sa preparation et utilisation pour enrober les formes solides ingerables |
PE20091809A1 (es) | 2008-04-17 | 2009-12-03 | Sanofi Aventis | Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad |
FR2930149B1 (fr) * | 2008-04-17 | 2011-02-18 | Sanofi Aventis | Association de dronedarone avec au moins un diuretique, son application en therapeutique |
EP2116239A1 (en) * | 2008-04-29 | 2009-11-11 | Sanofi-Aventis | Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment |
US8728516B2 (en) * | 2009-04-30 | 2014-05-20 | Abbvie Inc. | Stabilized lipid formulation of apoptosis promoter |
TWI540132B (zh) * | 2009-06-08 | 2016-07-01 | 亞培公司 | Bcl-2族群抑制劑之口服醫藥劑型 |
TWI532484B (zh) * | 2009-06-08 | 2016-05-11 | 艾伯維有限公司 | 包含凋亡促進劑之固態分散劑 |
CN102078307B (zh) * | 2009-12-01 | 2012-11-07 | 天津市汉康医药生物技术有限公司 | 一种盐酸决奈达隆固体分散体的药物组合物及其制备方法 |
WO2011072141A1 (en) | 2009-12-11 | 2011-06-16 | Neuron Systems, Inc. | Compositions and methods for the treatment of macular degeneration |
WO2011135582A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Pharmaceutical compositions of dronedarone |
WO2011135581A2 (en) | 2010-04-28 | 2011-11-03 | Cadila Healthcare Limited | Pharmaceutical compositions of dronedarone |
CA2798084A1 (en) | 2010-05-17 | 2011-11-24 | Aerie Pharmaceuticals, Inc. | Drug delivery devices for delivery of ocular therapeutic agents |
WO2012001673A1 (en) * | 2010-06-28 | 2012-01-05 | Mapi Pharma Holdings (Cyprus) Limited | Amorphous form of dronedarone |
US8602215B2 (en) | 2010-06-30 | 2013-12-10 | Sanofi | Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation |
CN102342907A (zh) | 2010-07-30 | 2012-02-08 | 江苏恒瑞医药股份有限公司 | 决奈达隆固体分散体及其制备方法 |
US20130142849A1 (en) | 2010-08-17 | 2013-06-06 | Lupin Limited | Controlled release formulations of dronedarone |
UA113500C2 (xx) | 2010-10-29 | 2017-02-10 | Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб | |
US9204667B2 (en) * | 2010-12-01 | 2015-12-08 | R.J. Reynolds Tobacco Company | Smokeless tobacco pastille and injection molding process for forming smokeless tobacco products |
WO2013024411A1 (en) | 2011-08-12 | 2013-02-21 | Lupin Limited | Co-milled formulation of dronedarone |
JP2015507003A (ja) | 2012-02-20 | 2015-03-05 | ルピン・リミテッドLupin Limited | ドロネダロンの二層錠剤 |
CN103054820B (zh) * | 2012-08-22 | 2016-07-13 | 石药集团中奇制药技术(石家庄)有限公司 | 一种盐酸决奈达隆药物组合物及其制备方法 |
JP6514114B2 (ja) | 2013-01-23 | 2019-05-15 | アルデイラ セラピューティクス, インコーポレイテッド | 毒性アルデヒド関連疾患および処置 |
EA029081B9 (ru) | 2013-01-31 | 2018-09-28 | Джилид Фармассет Ллс | Комбинированный состав двух противовирусных соединений |
SI3650014T1 (sl) | 2013-08-27 | 2022-01-31 | Gilead Pharmasset Llc | Formulacija kombinacije dveh protivirusnih spojin |
TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
WO2018046642A1 (en) * | 2016-09-09 | 2018-03-15 | Merck Patent Gmbh | Process for the manufacture of a solid pharmaceutical adminstration form |
US11040039B2 (en) | 2017-10-10 | 2021-06-22 | Aldeyra Therapeutics, Inc. | Treatment of inflammatory disorders |
AU2019319740A1 (en) | 2018-08-06 | 2021-03-25 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
WO2020198064A1 (en) | 2019-03-26 | 2020-10-01 | Aldeyra Therapeutics, Inc. | Ophthalmic formulations and uses thereof |
WO2020223685A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Polymorphic compounds and uses thereof |
WO2020223717A1 (en) | 2019-05-02 | 2020-11-05 | Aldeyra Therapeutics, Inc. | Process for preparation of aldehyde scavenger and intermediates |
EP4149470A4 (en) | 2020-05-13 | 2024-04-24 | Aldeyra Therapeutics, Inc. | PHARMACEUTICAL FORMULATIONS AND USES THEREOF |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3612212A1 (de) * | 1986-04-11 | 1987-10-15 | Basf Ag | Verfahren zur herstellung von festen pharmazeutischen formen |
GB8613689D0 (en) * | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
US5456932A (en) * | 1987-04-20 | 1995-10-10 | Fuisz Technologies Ltd. | Method of converting a feedstock to a shearform product and product thereof |
CA2095776C (en) * | 1992-05-12 | 2007-07-10 | Richard C. Fuisz | Rapidly dispersable compositions containing polydextrose |
FR2692575B1 (fr) * | 1992-06-23 | 1995-06-30 | Sanofi Elf | Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5935600A (en) * | 1993-09-10 | 1999-08-10 | Fuisz Technologies Ltd. | Process for forming chewable quickly dispersing comestible unit and product therefrom |
TW487582B (en) * | 1995-08-11 | 2002-05-21 | Nissan Chemical Ind Ltd | Method for converting sparingly water-soluble medical substance to amorphous state |
FR2761266B1 (fr) * | 1997-03-28 | 1999-07-02 | Sanofi Sa | Composition pharmaceutique formee par granulation humide pour l'administration orale d'un derive du n-piperidino-3- pyrazolecarboxamide, de ses sels et de leurs solvates |
DE19938672C2 (de) | 1999-08-06 | 2001-11-22 | Biop Biopolymer Gmbh | Verfahren zur Herstellung einer thermoplastischen Polymermischung auf Stärkebasis durch reaktive Extrusion |
EP1401503B1 (en) * | 2001-06-22 | 2007-05-09 | Pfizer Products Inc. | Pharmaceutical compositions containing a solid dispersion of a poorly-soluble drug and a solubility-enhancing polymer |
US6566347B1 (en) * | 2001-08-22 | 2003-05-20 | Duquesne University Of The Holy Ghost | Controlled release pharmaceutical |
-
2004
- 2004-09-17 FR FR0409874A patent/FR2875409B1/fr not_active Expired - Lifetime
-
2005
- 2005-09-15 NZ NZ553780A patent/NZ553780A/en not_active IP Right Cessation
- 2005-09-15 EP EP05802489.4A patent/EP1791524B1/fr active Active
- 2005-09-15 WO PCT/FR2005/002288 patent/WO2006032762A2/fr active Application Filing
- 2005-09-15 CN CN2005800354363A patent/CN101039657B/zh not_active Expired - Fee Related
- 2005-09-15 ZA ZA200702214A patent/ZA200702214B/xx unknown
- 2005-09-15 AU AU2005286396A patent/AU2005286396B2/en not_active Ceased
- 2005-09-15 BR BRPI0515390-5A patent/BRPI0515390A/pt not_active IP Right Cessation
- 2005-09-15 JP JP2007531798A patent/JP5224812B2/ja not_active Expired - Fee Related
- 2005-09-15 CA CA2579673A patent/CA2579673C/fr not_active Expired - Fee Related
- 2005-09-15 CN CN2011100789108A patent/CN102247601A/zh active Pending
- 2005-09-15 EA EA200700658A patent/EA012850B1/ru not_active IP Right Cessation
- 2005-09-15 MX MX2007003162A patent/MX2007003162A/es active IP Right Grant
-
2007
- 2007-03-07 IL IL181773A patent/IL181773A0/en unknown
- 2007-03-14 MA MA29752A patent/MA28858B1/fr unknown
- 2007-03-15 US US11/686,611 patent/US9084730B2/en active Active
- 2007-04-11 NO NO20071853A patent/NO20071853L/no not_active Application Discontinuation
- 2007-04-16 KR KR1020077008644A patent/KR101342193B1/ko not_active IP Right Cessation
-
2008
- 2008-03-05 HK HK08102568.0A patent/HK1111608A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ553780A (en) | 2010-08-27 |
IL181773A0 (en) | 2007-07-04 |
ZA200702214B (en) | 2008-09-25 |
CA2579673C (fr) | 2014-11-18 |
EP1791524A2 (fr) | 2007-06-06 |
EP1791524B1 (fr) | 2014-11-19 |
KR20070055601A (ko) | 2007-05-30 |
CN101039657A (zh) | 2007-09-19 |
FR2875409B1 (fr) | 2010-05-07 |
EA200700658A1 (ru) | 2007-08-31 |
HK1111608A1 (en) | 2008-08-15 |
AU2005286396B2 (en) | 2011-08-11 |
WO2006032762A2 (fr) | 2006-03-30 |
EA012850B1 (ru) | 2009-12-30 |
CN102247601A (zh) | 2011-11-23 |
US20070243257A1 (en) | 2007-10-18 |
CA2579673A1 (fr) | 2006-03-30 |
KR101342193B1 (ko) | 2013-12-16 |
AU2005286396A1 (en) | 2006-03-30 |
BRPI0515390A (pt) | 2008-07-22 |
US9084730B2 (en) | 2015-07-21 |
CN101039657B (zh) | 2012-07-18 |
JP2008513421A (ja) | 2008-05-01 |
JP5224812B2 (ja) | 2013-07-03 |
MA28858B1 (fr) | 2007-09-03 |
FR2875409A1 (fr) | 2006-03-24 |
NO20071853L (no) | 2007-06-15 |
WO2006032762A3 (fr) | 2006-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007003162A (es) | Composicion farmaceutica que comprende una dispersion solida con una matriz polimerica que comprende una fase continua de polidextrosa y una fase continua de un polimero distinto de la polidextrosa. | |
SI1933809T1 (sl) | Sestavki za mazalno dajanje | |
PL1713446T3 (pl) | Nielamelarne trójskładnikowe kompozycje lipidów | |
MX2009000035A (es) | Formulaciones de agente activo, procedimientos de preparacion y procedimientos de uso. | |
MX2007013065A (es) | Derivados de dihidrobenzofurano y usos de los mismos. | |
WO2007056424A3 (en) | Controlled-release emulsion compositions | |
WO2007072189A3 (en) | A silylated polymer emulsion and its preparation method and uses thereof | |
RS20050066A (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
MY122668A (en) | Liquid compositions comprising stable emulsion of small particle skin benefit agent | |
JP2009516717A5 (es) | ||
TW200740427A (en) | Highly bioavailable oral delayed release dosage forms of O-desmethylvenlafaxine succinate | |
BR9809865A (pt) | Fixador de perfume, perfume e produto base misturados com o mesmo, e, produto perfumado. | |
WO2007014328A3 (en) | Compositions and methods for emulsifying a perfluorocarbon with an oxygen-carrying surfactant | |
BR0005034A (pt) | Composição herbicida | |
ATE430189T1 (de) | Wasch- oder reinigungsmittel | |
BRPI0412391A (pt) | formulação farmacêutica compreendendo levotiroxina sódica | |
TW200722075A (en) | Propofol-containing fat emulsion | |
BRPI0500623A (pt) | composição para regular o crescimento de insetos | |
AR018607A1 (es) | Preparacion farmaceutica que en calidad de ingrediente activo contiene levotiroxina sodica, y un procedimiento para su preparacion | |
MX2008010879A (es) | Composiciones farmaceuticas de sodio de fluvastatina. | |
ATE444739T1 (de) | Polymerzusammensetzung sowie diese enthaltende darreichungsformen | |
RS51578B (en) | SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITROMYCIN | |
ZA200705660B (en) | Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate | |
UA93540C2 (ru) | Фармацевтическая композиция для аэрозольного распыления c двумя действующими веществами и, по меньшей mepe, одним поверхностно-активным веществом | |
BR0212751A (pt) | Composição detergente sólida, e, barra detergente |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |